Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

83
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
83
Human Genetics01:28

Human Genetics

676
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
676
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

512
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
512
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

348
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
348
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

1.5K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virtual internal exposures of lansoprazole administered to cytochrome P450 2C19 poor metabolizers estimated by simplified physiologically based pharmacokinetic modeling.

The Journal of toxicological sciences·2026
Same author

Social skills moderate pain sensitivity during acute psychosocial stress: an experimental study using the Trier Social Stress Test.

Journal of physiological anthropology·2026
Same author

Implant‑position reproducibility of wired and wireless intraoral scanners and the effects of Wi‑Fi distance and upload speed: an in vitro study.

BMC oral health·2026
Same author

Effect of blood microsampling (50 μL) on toxicological assessment in rats treated with tacrine, a drug known to have adverse effects that increase neutrophils.

The Journal of toxicological sciences·2026
Same author

Pain Qualities Associated With Body Perception Disturbances: Insights From Machine Learning and SHapley Additive exPlanations.

Archives of physical medicine and rehabilitation·2025
Same author

Method validation and assessment of the biodistribution and shedding for adenovirus vector-based vaccine using qPCR and dPCR.

Molecular therapy. Methods & clinical development·2025

Related Experiment Video

Updated: Aug 22, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

825

[Pharmacogenomics in hematological malignancy].

Yoichi Tanaka1

  • 1Division of Medicinal Safety Science, National Institute of Health Sciences.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|November 9, 2022
PubMed
Summary

Genetic variants influence how patients respond to leukemia drugs like 6-mercaptopurine (6-MP). This review highlights associations between genetic variations and drug efficacy and toxicity in hematological malignancies.

Keywords:
CytarabineMercaptopurineNUDT15Pharmacogenomics

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.5K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.3K

Related Experiment Videos

Last Updated: Aug 22, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

825
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.5K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.3K

Area of Science:

  • Pharmacogenomics
  • Hematology
  • Genetics

Background:

  • Genetic variants in drug-metabolizing enzymes and transporters impact therapeutic response and drug toxicity.
  • Genome-wide association studies (GWASs) have identified new genetic variants linked to drug response.
  • Predictive models using multiple single-nucleotide polymorphisms (SNPs) are emerging for therapeutic response.

Conclusions:

  • Genetic variations significantly influence treatment outcomes for hematological malignancies.
  • Pharmacogenomic insights are crucial for personalizing chemotherapy regimens.
  • Further research is needed to validate and apply genetic findings in broader patient groups.